Detalles de la búsqueda
1.
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC.
Int J Mol Sci
; 24(2)2023 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674503
2.
Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib.
Anticancer Drugs
; 32(7): 758-762, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33675607
3.
Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells.
Int J Mol Sci
; 21(14)2020 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32708306
4.
Cap-independent protein synthesis is enhanced by betaine under hypertonic conditions.
Biochem Biophys Res Commun
; 483(3): 936-940, 2017 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28082201
5.
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.
Tumour Biol
; 39(4): 1010428317695023, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28378631
6.
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance.
Mol Cancer
; 13: 143, 2014 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24898067
7.
Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy".
Breast Cancer Res Treat
; 144(1): 113-21, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24469643
8.
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models.
Sci Rep
; 14(1): 6491, 2024 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38499619
9.
5'-Untranslated region of heat shock protein 70 mRNA drives translation under hypertonic conditions.
Biochem Biophys Res Commun
; 431(2): 321-5, 2013 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-23291172
10.
Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Breast Cancer Res Treat
; 141(1): 67-78, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23963659
11.
Long-lasting inhibition of EGFR autophosphorylation in A549 tumor cells by intracellular accumulation of non-covalent inhibitors.
Bioorg Med Chem Lett
; 23(19): 5290-4, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23988354
12.
Interaction between Occupational and Non-Occupational Arsenic Exposure and Tobacco Smoke on Lung Cancerogenesis: A Systematic Review.
Int J Environ Res Public Health
; 20(5)2023 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36901176
13.
A Photoactive Supramolecular Complex Targeting PD-L1 Reveals a Weak Correlation between Photoactivation Efficiency and Receptor Expression Levels in Non-Small-Cell Lung Cancer Tumor Models.
Pharmaceutics
; 15(12)2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140116
14.
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators.
Target Oncol
; 18(6): 953-964, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855989
15.
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines.
Mol Cancer
; 11: 91, 2012 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23234355
16.
Interaction between occupational radon exposure and tobacco smoke: a systematic review.
Expert Rev Respir Med
; 16(7): 787-800, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35912519
17.
CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells.
Cancers (Basel)
; 14(23)2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36497412
18.
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells.
Front Oncol
; 12: 942341, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35936714
19.
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs.
JTO Clin Res Rep
; 3(2): 100278, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35199053
20.
Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines.
Mol Cancer
; 10: 143, 2011 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-22111840